| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Carsten Hjorthøj, Christine Merrild Posselt, Merete Nordentof. Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark. JAMA psychiatry. vol 78. issue 9. 2021-09-02. PMID:34287621. |
if the association between cannabis use and schizophrenia is causal, this should be reflected in an increase in the proportion of cases of schizophrenia being attributable to cannabis, the population-attributable risk fraction (parf). |
2021-09-02 |
2023-08-13 |
Not clear |
| James Vaissiere, Jackson G Thorp, Jue-Sheng Ong, Alfredo Ortega-Alonzo, Eske M Derk. Exploring Phenotypic and Genetic Overlap Between Cannabis Use and Schizotypy. Twin research and human genetics : the official journal of the International Society for Twin Studies. vol 23. issue 4. 2021-09-01. PMID:32885772. |
recent studies have observed significant genetic overlap between a diagnosis of schizophrenia and lifetime cannabis use. |
2021-09-01 |
2023-08-13 |
Not clear |
| Jesper Østrup Rasmussen, Poul Jennum, Kristian Linnet, Birte Y Glenthøj, Lone Baandru. Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial. BMC psychiatry. vol 21. issue 1. 2021-08-26. PMID:34391393. |
cannabis use is an important risk factor for development of psychosis and further transition to schizophrenia. |
2021-08-26 |
2023-08-13 |
Not clear |
| Luca De Peri, Rafael Traber, Emilio Bolla, Antonio Vit. Are Schizophrenic disorders with or without early cannabis use neurobiologically distinct disease entities? A meta-analysis of magnetic resonance imaging studies. Psychiatry research. vol 297. 2021-08-19. PMID:33493730. |
this study aimed to determine through a meta-analytic approach whether patients at the onset of schizophrenia with comorbid cannabis use (sch cu+) show a different pattern of brain abnormalities as compared to patients with no comorbid cannabis use (sch cu-). |
2021-08-19 |
2023-08-13 |
Not clear |
| Matthew S Lebowitz, Paul S Appelbaum, Lisa B Dixon, Ragy R Girgis, Melanie M Wal. Experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk. Journal of psychiatric research. vol 140. 2021-08-05. PMID:34126426. |
experimentally exploring the potential behavioral effects of personalized genetic information about marijuana and schizophrenia risk. |
2021-08-05 |
2023-08-13 |
human |
| Kristina M Gicas, Alex Cheng, William J Panenka, David D Kim, Jade C Yau, Ric M Procyshyn, Jacob L Stubbs, Andrea A Jones, Simran Bains, Allen E Thornton, Donna J Lang, Alexandra T Vertinsky, Alex Rauscher, William G Honer, Alasdair M Bar. Differential effects of cannabis exposure during early versus later adolescence on the expression of psychosis in homeless and precariously housed adults. Progress in neuro-psychopharmacology & biological psychiatry. vol 106. 2021-07-27. PMID:32890696. |
results indicated that early cannabis exposure was associated with an increased risk (or = 1.09, p < .05) of developing substance induced psychosis, whereas later first use increased risk (or = 2.19, p < .01) of developing schizophrenia or schizoaffective disorder. |
2021-07-27 |
2023-08-13 |
human |
| Kurt Leroy Hoffma. From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia. Frontiers in psychiatry. vol 12. 2021-07-23. PMID:34290632. |
the present mini-review focuses on animal models of schizophrenia that have explored the effects of cannabidiol (cbd; a non-psychoactive component of cannabis) or the pharmacological manipulation of the endocannabinoid system on behavioral and cognitive outcome measures. |
2021-07-23 |
2023-08-13 |
Not clear |
| Katelyn Grechuk, Heela Azizi, Vatsala Sharma, Tasmia Khan, Ayodeji Jolayem. Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism. Cureus. vol 13. issue 6. 2021-07-22. PMID:34285849. |
cannabis, schizophrenia risk and genetics: a case report of a patient with homozygous valine catechol-o-methyltransferase polymorphism. |
2021-07-22 |
2023-08-13 |
human |
| Katelyn Grechuk, Heela Azizi, Vatsala Sharma, Tasmia Khan, Ayodeji Jolayem. Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism. Cureus. vol 13. issue 6. 2021-07-22. PMID:34285849. |
the question of whether cannabis can trigger schizophrenia continues to be a subject of interest. |
2021-07-22 |
2023-08-13 |
human |
| Katelyn Grechuk, Heela Azizi, Vatsala Sharma, Tasmia Khan, Ayodeji Jolayem. Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism. Cureus. vol 13. issue 6. 2021-07-22. PMID:34285849. |
there has been an increasing focus on identifying potential genetic factors that may predispose cannabis users to develop schizophrenia. |
2021-07-22 |
2023-08-13 |
human |
| Katelyn Grechuk, Heela Azizi, Vatsala Sharma, Tasmia Khan, Ayodeji Jolayem. Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism. Cureus. vol 13. issue 6. 2021-07-22. PMID:34285849. |
the latter is of interest in truly understanding the risk of cannabis triggering schizophrenia and more studies are needed to clarify the potential relationship. |
2021-07-22 |
2023-08-13 |
human |
| Katelyn Grechuk, Heela Azizi, Vatsala Sharma, Tasmia Khan, Ayodeji Jolayem. Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism. Cureus. vol 13. issue 6. 2021-07-22. PMID:34285849. |
we present the case of a 24-year-old female who presented with psychotic symptoms and was diagnosed with schizophrenia after extensive cannabis use. |
2021-07-22 |
2023-08-13 |
human |
| Katelyn Grechuk, Heela Azizi, Vatsala Sharma, Tasmia Khan, Ayodeji Jolayem. Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism. Cureus. vol 13. issue 6. 2021-07-22. PMID:34285849. |
in addition, she had a homozygous valine comt polymorphism, a genetic variant thought to be associated with a predisposition for schizophrenia in cannabis users. |
2021-07-22 |
2023-08-13 |
human |
| Katelyn Grechuk, Heela Azizi, Vatsala Sharma, Tasmia Khan, Ayodeji Jolayem. Cannabis, Schizophrenia Risk and Genetics: A Case Report of a Patient With Homozygous Valine Catechol-O-Methyltransferase Polymorphism. Cureus. vol 13. issue 6. 2021-07-22. PMID:34285849. |
we discuss the significance of our findings in understanding the relationship between cannabis use and the development of schizophrenia in genetically predisposed individuals. |
2021-07-22 |
2023-08-13 |
human |
| F Scheffler, S Du Plessis, L Asmal, S Kilian, L Phahladira, H K Luckhoff, R Emsle. Cannabis use and hippocampal subfield volumes in males with a first episode of a schizophrenia spectrum disorder and healthy controls. Schizophrenia research. vol 231. 2021-07-05. PMID:33740561. |
both schizophrenia and cannabis use are associated with structural brain changes. |
2021-07-05 |
2023-08-13 |
Not clear |
| Simon Fish, Foteini Christidi, Efstratios Karavasilis, Georgios Velonakis, Nikolaos Kelekis, Christoph Klein, Nicholas C Stefanis, Nikolaos Smyrni. Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity. NPJ schizophrenia. vol 7. issue 1. 2021-07-02. PMID:34135344. |
interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity. |
2021-07-02 |
2023-08-13 |
human |
| Simon Fish, Foteini Christidi, Efstratios Karavasilis, Georgios Velonakis, Nikolaos Kelekis, Christoph Klein, Nicholas C Stefanis, Nikolaos Smyrni. Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity. NPJ schizophrenia. vol 7. issue 1. 2021-07-02. PMID:34135344. |
chronic cannabis use and schizophrenia are both thought to affect reward processing. |
2021-07-02 |
2023-08-13 |
human |
| Simon Fish, Foteini Christidi, Efstratios Karavasilis, Georgios Velonakis, Nikolaos Kelekis, Christoph Klein, Nicholas C Stefanis, Nikolaos Smyrni. Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity. NPJ schizophrenia. vol 7. issue 1. 2021-07-02. PMID:34135344. |
in the present study eighty-nine participants divided into four groups (control chronic cannabis users and non-users; schizophrenia patient cannabis users and non-users) performed a two-choice decision task, preceded by monetary cues (high/low reward/punishment or neutral), while being scanned using functional magnetic resonance imaging. |
2021-07-02 |
2023-08-13 |
human |
| Simon Fish, Foteini Christidi, Efstratios Karavasilis, Georgios Velonakis, Nikolaos Kelekis, Christoph Klein, Nicholas C Stefanis, Nikolaos Smyrni. Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity. NPJ schizophrenia. vol 7. issue 1. 2021-07-02. PMID:34135344. |
chronic cannabis use and schizophrenia had opposing effects on reward anticipation sensitivity. |
2021-07-02 |
2023-08-13 |
human |
| Simon Fish, Foteini Christidi, Efstratios Karavasilis, Georgios Velonakis, Nikolaos Kelekis, Christoph Klein, Nicholas C Stefanis, Nikolaos Smyrni. Interaction of schizophrenia and chronic cannabis use on reward anticipation sensitivity. NPJ schizophrenia. vol 7. issue 1. 2021-07-02. PMID:34135344. |
this study provided evidence for interaction of chronic cannabis use and schizophrenia on reward processing and highlights the need for future research addressing the significance of this interaction for the pathophysiology of these conditions and its clinical consequences. |
2021-07-02 |
2023-08-13 |
human |